These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 33646714)

  • 1. Factors Associated With Relapse in Individuals With Opioid Use Disorder Receiving Suboxone in Rural Areas.
    Chang YP; Raynor T
    J Addict Nurs; 2021 Jan-Mar 01; 32(1):20-26. PubMed ID: 33646714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse childhood experiences predict opioid relapse during treatment among rural adults.
    Derefinko KJ; Salgado García FI; Talley KM; Bursac Z; Johnson KC; Murphy JG; McDevitt-Murphy ME; Andrasik F; Sumrok DD
    Addict Behav; 2019 Sep; 96():171-174. PubMed ID: 31102882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group-based treatment of opioid use disorder with buprenorphine: A systematic review.
    Sokol R; LaVertu AE; Morrill D; Albanese C; Schuman-Olivier Z
    J Subst Abuse Treat; 2018 Jan; 84():78-87. PubMed ID: 29195596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder.
    Montalvo C; Genovese N; Renner J
    Subst Abus; 2019; 40(2):136-139. PubMed ID: 30835647
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline in Buprenorphine/Naloxone Prescriptions in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail.
    Soper R; Appajosyula S; Deximo C
    Adv Ther; 2018 Apr; 35(4):457-466. PubMed ID: 29623562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
    Bozinoff N; DeBeck K; Milloy MJ; Nosova E; Fairbairn N; Wood E; Hayashi K
    Drug Alcohol Depend; 2018 Dec; 193():42-47. PubMed ID: 30340144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada.
    Sud A; McGee M; Mintzes B; Herder M
    Int J Drug Policy; 2022 Jul; 105():103749. PubMed ID: 35643048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County.
    Beachler T; Zeller TA; Heo M; Lanzillotta-Rangeley J; Litwin AH
    J Rural Health; 2021 Jan; 37(1):29-34. PubMed ID: 32738095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017.
    Luu H; Slavova S; Freeman PR; Lofwall M; Browning S; Slade E; Bush H
    Drug Alcohol Depend; 2019 Dec; 205():107606. PubMed ID: 31606590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
    Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
    J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Relapse in Patients with Opioid-Use Disorder and Chronic Non-Cancer Pain.
    Nwaefuna PN
    Pain Manag Nurs; 2024 Apr; 25(2):189-194. PubMed ID: 38036409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013.
    Turner L; Kruszewski SP; Alexander GC
    Am J Addict; 2015 Jan; 24(1):24-9. PubMed ID: 25823632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of opioid use disorders: a national clinical practice guideline.
    Bruneau J; Ahamad K; Goyer MÈ; Poulin G; Selby P; Fischer B; Wild TC; Wood E;
    CMAJ; 2018 Mar; 190(9):E247-E257. PubMed ID: 29507156
    [No Abstract]   [Full Text] [Related]  

  • 17. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.
    Evans EA; Zhu Y; Yoo C; Huang D; Hser YI
    Addiction; 2019 Aug; 114(8):1396-1404. PubMed ID: 30916463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis.
    Sud A; Strang M; Buchman DZ; Spithoff S; Upshur REG; Webster F; Grundy Q
    BMJ Open; 2022 Jul; 12(7):e059561. PubMed ID: 35820738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.